Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 216

Similar articles for PubMed (Select 19932544)

1.

Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Jan;55(1):31-41. doi: 10.1053/j.ajkd.2009.09.006. Epub 2009 Nov 22.

PMID:
19932544
2.

Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).

Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ.

Am J Kidney Dis. 2015 Mar;65(3):394-402. doi: 10.1053/j.ajkd.2014.07.026. Epub 2014 Oct 14.

PMID:
25441435
3.

Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.

Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG.

Am J Kidney Dis. 2008 Aug;52(2):251-61. doi: 10.1053/j.ajkd.2008.03.019. Epub 2008 May 12.

PMID:
18468746
4.

Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).

Babayev R, Whaley-Connell A, Kshirsagar A, Klemmer P, Navaneethan S, Chen SC, Li S, McCullough PA, Bakris G, Bomback A; KEEP Investigators.

Am J Kidney Dis. 2013 Mar;61(3):404-12. doi: 10.1053/j.ajkd.2012.11.038. Epub 2012 Dec 20.

PMID:
23260275
5.

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.

O'Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS.

Am J Kidney Dis. 2011 Jun;57(6):841-9. doi: 10.1053/j.ajkd.2010.11.022. Epub 2011 Feb 3.

6.

Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2444-51. doi: 10.2215/CJN.00580111. Epub 2011 Aug 18.

7.

Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Apr;55(4):648-59. doi: 10.1053/j.ajkd.2009.12.016. Epub 2010 Feb 26.

8.

Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.

Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG.

Am J Kidney Dis. 2012 May;59(5):628-35. doi: 10.1053/j.ajkd.2011.10.050. Epub 2011 Dec 28.

9.

Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.

Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.

Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.

PMID:
23993165
10.

End-stage renal disease in African-American and white men. 16-year MRFIT findings.

Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J.

JAMA. 1997 Apr 23-30;277(16):1293-8.

PMID:
9109467
11.

The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.

De Nicola L, Minutolo R, Chiodini P, Borrelli S, Zoccali C, Postorino M, Iodice C, Nappi F, Fuiano G, Gallo C, Conte G; Italian Society of Nephrology Study Group Target Blood pressure Levels (TABLE) in CKD.

Kidney Int. 2012 Aug;82(4):482-8.

PMID:
22622495
12.

CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.

Hui X, Matsushita K, Sang Y, Ballew SH, Fülöp T, Coresh J.

Am J Kidney Dis. 2013 Oct;62(4):691-702. doi: 10.1053/j.ajkd.2013.04.010. Epub 2013 Jun 13.

13.

Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

Tanner RM, Calhoun DA, Bell EK, Bowling CB, Gutiérrez OM, Irvin MR, Lackland DT, Oparil S, McClellan W, Warnock DG, Muntner P.

Am J Kidney Dis. 2014 May;63(5):781-8. doi: 10.1053/j.ajkd.2013.11.016. Epub 2014 Jan 1. Review.

14.

Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD.

McClellan WM, Warnock DG, Judd S, Muntner P, Patzer RE, Bradbury BD, McClure LA, Newsome BB, Howard G.

Am J Kidney Dis. 2012 Jan;59(1):25-31. doi: 10.1053/j.ajkd.2011.09.018. Epub 2011 Nov 10.

15.

Risk factors for end-stage renal disease: 25-year follow-up.

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS.

Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605.

16.

Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J.

J Am Soc Nephrol. 2007 Apr;18(4):1307-15. Epub 2007 Mar 7.

17.

Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators.

Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30.

18.

Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).

Chang TI, Li S, Chen SC, Peralta CA, Shlipak MG, Fried LF, Whaley-Connell AT, McCullough PA, Tamura MK; KEEP Investigators.

Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S4-11. doi: 10.1053/j.ajkd.2012.12.016.

19.
20.

Chronic kidney disease and the risk of end-stage renal disease versus death.

Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L.

J Gen Intern Med. 2011 Apr;26(4):379-85. doi: 10.1007/s11606-010-1511-x. Epub 2010 Sep 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk